“St. Jude Children’s Hospital has received two grants worth more than $4.35 million.
“The funding came through the National Institutes of Health’s Pharmacogenomics Research Network, which St. Jude has been a part of since 2000. It represents the fourth funding cycle for St. Jude from PGRN.
A portion of the funding will be used to create a new Center for Precision Medicine in Leukemia. Another $1.22 million of the funds will be used for a Clinical Pharmacogenetis Implementation Consortium.
The Center for Precision Medicine in Leukemia will be led by Mary Relling, chair of the Pharmaceutical Department at St. Jude, and Mignon Loh, division chief, Pediatric Hematology Oncology at the University of California San Francisco.
The goal of the center is to optimize treatment for acute leukemia while translating genomics into more effective and less toxic treatment of children and adults with leukemia. The research would also help integrate precision medicine into treatments of other diseases.”
St. Jude Children’s Research Hospital receives $4.3 million grant from National Institutes of Health – Memphis Business Journal.